V. Shetty | Authors

Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide

November 01, 2000

Myelodysplastic syndrome patients present with variable cytopenias even though their bone marrows are generally hypercellular. Excessive cytokine-induced apoptosis of hematopoietic cells in the marrows has been proposed as a possible